|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0017636,
umls-concept:C0023745,
umls-concept:C0087071,
umls-concept:C0185117,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0598002,
umls-concept:C0750502,
umls-concept:C1384539,
umls-concept:C2911684
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2005-11-2
|
|
pubmed:abstractText |
Several tumor suppressor pathways have been identified as modulators of telomerase function. We examined the functional role of the retinoblastoma-E2F1 pathway in regulating telomerase activity in malignant gliomas.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1460-2105
|
|
pubmed:author |
pubmed-author:AldapeKenneth DKD,
pubmed-author:AlonsoMarta MMM,
pubmed-author:BekeleB NebiyouBN,
pubmed-author:FueyoJuanJ,
pubmed-author:Gomez-ManzanoCandelariaC,
pubmed-author:HongJiangJ,
pubmed-author:JohnsonDavid GDG,
pubmed-author:KanzawaTakaoT,
pubmed-author:KondoYasukoY,
pubmed-author:KyoSatoruS,
pubmed-author:LeeOk-HeeOH,
pubmed-author:McDonaldJ MatthewJM,
pubmed-author:NigroJaniceJ,
pubmed-author:ShayJerry WJW,
pubmed-author:XuJingJ,
pubmed-author:YungW K AlfredWK,
pubmed-author:ZhouXianX
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
2
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1589-600
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16264179-Animals,
pubmed-meshheading:16264179-Brain Neoplasms,
pubmed-meshheading:16264179-Cell Line, Tumor,
pubmed-meshheading:16264179-Chromatin Immunoprecipitation,
pubmed-meshheading:16264179-DNA-Binding Proteins,
pubmed-meshheading:16264179-E2F1 Transcription Factor,
pubmed-meshheading:16264179-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:16264179-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16264179-Genetic Linkage,
pubmed-meshheading:16264179-Glioblastoma,
pubmed-meshheading:16264179-Humans,
pubmed-meshheading:16264179-Immunoblotting,
pubmed-meshheading:16264179-Mice,
pubmed-meshheading:16264179-Mice, Transgenic,
pubmed-meshheading:16264179-Predictive Value of Tests,
pubmed-meshheading:16264179-Prognosis,
pubmed-meshheading:16264179-Promoter Regions, Genetic,
pubmed-meshheading:16264179-RNA, Messenger,
pubmed-meshheading:16264179-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16264179-Sarcoma,
pubmed-meshheading:16264179-Telomerase
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
|
|
pubmed:affiliation |
Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|
